BREI

BREI – Brazilian Real Estate Investments Ltda. (CNPJ 14.744.231/0001-14) is a boutique asset manager based in São Paulo, authorized by CVM since March 2014 (Declaratory Act No. 13,584). It is part of the Integral Group — a platform that, since the 2015 merger between BREI and Integral Investimentos, combines expertise in structured credit and real estate management. With approximately R$ 1.17 billion in AUM distributed between two active funds — IBCR11 (R$ 86 million in high-yield CRIs) and FII Biotic (R$ 1.08 billion in urban development of the Brasília Technology Park) —, BREI occupies a niche position in the market: it is small in terms of listed funds, but expressive when considering the non-exchange-traded fund. Integral Group is a signatory to the Carbon Disclosure Program (CDP), Principles for Responsible Investment (PRI), and the UN Global Compact.

Track record and governance

BREI's history reveals a trajectory of high-risk product selection and significant discontinuity: out of 13 funds established throughout its existence, 9 were canceled — a shutdown rate of over 69%. In its only exchange-listed FII (IBCR11), the manager currently faces two simultaneous credit events: the CRVO CRI (27% of NAV, Unidasul BTS in São Leopoldo/RS, with early maturity following the RS floods in January 2026) and the Olimpo CRI (7.2% of NAV, in default since January 2025). Management's communication has been technically adequate — management reports detail the events and defend the guarantees —, but the invariably defensive rhetoric ("appraisal exceeds debt balance") contrasts with the negative post-IPO IRR on the unit price (-8% p.a. before dividends). Administration of IBCR11 is performed by BTG Pactual Serviços Financeiros DTVM, which provides operational robustness to the back-office.

Strategy and funds under management

BREI operates in two opposing strategic vectors: high-yield real estate credit via CRIs (IBCR11) and public-based urban development (FII Biotic, in partnership with BIOTIC S.A., a DF public company). This diversity of models reflects the nature of a boutique manager serving specific mandates, but raises questions about focus and the replicability of expertise. In IBCR11, the strategy focuses on IPCA+ CRIs with an HTM rate of 9.77% and a duration of 6.54 years, covering residential completion of works, BTS, land subdivision, and logistics inventory segments. The portfolio has exposure concentrated in 11 CRIs, with two of them — CRVO and Olimpo — representing about 34% of NAV in a stressed situation. FII Biotic, being a development fund linked to a public entity, has a fundamentally different nature and is not accessible to retail investors via the stock exchange.

Strengths and points of attention

• Integration into Integral Group: access to structured credit and FIDC infrastructure from one of the segment's largest independent players, with analytical capacity above what IBCR11's size would suggest.
• Relevant AUM via FII Biotic: the manager moves an expressive volume (R$ 1.08 billion) in a public mandate, demonstrating the ability to structure large-scale products.
• Institutional ESG: formal commitment to CDP, PRI, and the Global Compact, a differentiator for investors with ESG criteria.

• High fund cancellation rate: 9 out of 13 products shut down indicates difficulty in viability and scaling vehicles, raising doubts about the long-term durability of IBCR11.
• History of credit underperformance: inadequate risk selection in IBCR11 — two simultaneous credit events in a portfolio of 11 CRIs represents an unusual concentration of problems for a relatively diversified portfolio.
• Collateral execution risk: IBCR11's thesis today depends on a successful auction of CRVO and the recovery of Olimpo within 12–24 months, factors outside the manager's direct control.
• Reduced liquidity: with only ~3,900 unitholders and an NAV of R$ 86 million, IBCR11 is a small fund, with a high bid-ask spread and greater secondary market unit volatility.

For which investor does it make sense

BREI, via IBCR11, is most suitable for investors with an aggressive profile and a 2-3 year horizon who are willing to bet on the recovery of guarantees for stressed CRIs. The ~45% discount to NAV is mathematically attractive if collateral executions come close to the appraisal value, but the manager's track record does not convey enough conviction to classify this as low-risk asymmetry. Monitor management reports monthly: any updates on the CRVO auction (São Leopoldo/RS) and Olimpo negotiations are the main thermometer of the fund's real value. Conservative investors or those with a horizon under 24 months should avoid it.